967285-000010 (blue crimp/black cap) — Aavant Retatrutide
Vendor COAAavant | Retatrutide, last activity 2 months ago
Aavant seldom publishes certificates, making this one of few batches where they have. The vendor's Janoshik certificate reports 99.87% purity and confirms identity, with measured fill at 27.82 mg. This result is in line with other retatrutide batches and slightly above this vendor's historical average of 99.44%.
5 related batch concerns · summary from 1 source · updated Aug 15
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Test Results
The label says 24 mg. Janoshik weighed 27.8 mg — 16% more than the label. Your dose depends on what is really in the vial, so the steps below use the measured amount.
Draw
17 units
on a U-100 insulin syringe, for 2.4 mg
Going by the label you would draw 20 units — which from this vial is actually 2.78 mg, not 2.4 mg.
- The vial holds dry powder: 27.8 mg of Retatrutide, as weighed.
- Water spreads that powder evenly through the liquid: 27.8 mg ÷ 2 ml = 13.9 mg per ml.
- An insulin syringe counts in units, 100 to the ml, so each unit carries 139 mcg.
- Your dose divided by that: 2.4 mg ÷ 139 mcg = 17 units.
The water changes how many units a dose takes, never how much peptide you get. Twice the water means twice the units for the same dose. What sets the dose is how much is in the vial — which is why the measured amount matters.
Arithmetic, not medical advice. Assumes a U-100 syringe and that the powder fully dissolves. The figure is from the vial that was tested; yours is from the same lot but was not weighed itself.
Related batches
5 of 5 tested
same lot series
1 community mention, no summary yet
same lot series
Tirzepatide, same vendor
1 community mention, no summary yet
APS
An independent test found endotoxin at 1,437.86 EU/vial, far exceeding the 10 EU/vial working limit, while the vendor's…
same lot series
Community Intelligence
- 1 concern report involving REPTN
- 2 concern reports involving 2026041210
- 4 concern reports involving XTP-R30-003
- 1 concern report involving JP20250821
- 1 concern report involving REPTN-1
Reported against other Aavant Retatrutide batches, not this one.
Also known as: 967285000010 (blue crimp/black cap)
Activity
No community activity tracked yet.
Vendor
Aavant